Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review
2017 · Journal of the Formosan Medical Association · 27 citations
https://doi.org/10.1016/j.jfma.2017.03.010
M
Ming‐Mo Hou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
1.6K
Citations
19
h-index
30
i10-index
Ming‐Mo Hou is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Palliative Care and End-of-Life Issues & Cancer Immunotherapy and Biomarkers & Hepatocellular Carcinoma Treatment and Prognosis. The author has an h-index of 19, co-authored 60 publications.
Papers by this author
worksGut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer
2024 · Biomedical Journal · 20 citations
https://doi.org/10.1016/j.bj.2024.100698
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience
2015 · Gynecologic Oncology Research and Practice · 11 citations
https://doi.org/10.1186/s40661-015-0018-x
Personalized neoantigen-based T cell therapy triggers cytotoxic lymphocytes expressing polyclonal TCR against metastatic ovarian cancer
2023 · Biomedicine & Pharmacotherapy · 9 citations
https://doi.org/10.1016/j.biopha.2023.115928
Modifiable factors of depressive-symptom trajectories from caregiving through bereavement
2022 · BMC Palliative Care · 2 citations
https://doi.org/10.1186/s12904-022-01045-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat